subscribeSubscribe
price-trendAsk Us
Takeda Announces Phase 3 Results For Soticlestat In Lennox-Gastaut Syndrome

Takeda Announces Phase 3 Results For Soticlestat In Lennox-Gastaut Syndrome
BUSINESSWIRE
17 Jun 2024
Share Share
Ovid Reports On Takeda’s Phase 3 Topline Results For Soticlestat

Ovid Reports On Takeda’s Phase 3 Topline Results For Soticlestat
GLOBENEWSWIRE
17 Jun 2024
Share Share
Epilepsy fail hands late-stage pipeline blow to Takeda

Epilepsy fail hands late-stage pipeline blow to Takeda
Phil Taylor PHARMAPHORUM
17 Jun 2024
Share Share
Takeda takes full control of drug for rare epilepsies

Takeda takes full control of drug for rare epilepsies
Jacob Bell BIOPAHRAMADIVE
04 Mar 2021
Share Share
Takeda, Ovid Therapeutics announce phase 2 ELEKTRA study of soticlestat

Takeda, Ovid Therapeutics announce phase 2 ELEKTRA study of soticlestat
PHARMABIZ
27 Aug 2020
Share Share
New data lead Ovid, Takeda to push seizure drug into final testing

New data lead Ovid, Takeda to push seizure drug into final testing
Jacob Bell BIOPHARMADIVE
27 Aug 2020
Share Share
New data lead Ovid, Takeda to push seizure drug into final testing

New data lead Ovid, Takeda to push seizure drug into final testing
J. Bell BIOPHARMADIVE
25 Aug 2020
Share Share
Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint

Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint
PRESS RELEASE
25 Aug 2020
Share Share